Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies

Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer NCI-AHEP0731

Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

Description:

For complete study information, please visit clinicaltrials.gov.

Study Status:

Closed

Full IRB Study Title:

Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment

IRB Study ID:

1038464 -1

If you are interested in this study or have questions about your child's eligibility, please contact:

Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org

While we are ranked among the best children's hospitals in the country, it's our compassionate approach to treatment that makes us truly exceptional. Through a combination of revolutionary treatments and extraordinary patient experiences, our care does more than heal. It brings the entire family together for emotional support and understanding across multiple locations to reach you in the community where you live. Learn more...